News Release

ELMSFORD, N.Y., Oct. 4, 2001 /PRNewswire/ -- MIM Corporation (Nasdaq: MIMS), a pharmaceutical healthcare organization, today announced that the Chicago Board Options Exchange (CBOE) will list options on the Company, effective today.

The Company's options will be listed under CBOE ticker symbol DUM. According to CBOE, DUM options will trade on the January expiration cycle with introductory expirations in October, November, January and April. Initial strike prices have been set at 7-1/2, 10 and 12-1/2. Spear, Leeds & Kellog has been named the Designated Primary Market Maker in the options.

MIM Corporation (www.mimcorporation.com) is a pharmaceutical healthcare organization managing and delivering innovative, cost-effective pharmacy benefits, which enhance the quality of patient lives. MIM's innovative pharmacy benefit products and services use clinically sound guidelines to ensure cost control and quality care. MIM's specialty pharmaceutical division specializes in serving the chronically ill affected by life threatening diseases. MIM's fulfillment operations specialize in serving individuals that require long-term maintenance medications. MIM's online pharmacy, www.MIMRx.com, develops private label websites to offer affinity groups and healthcare providers innovative, customized, health information services and products on the Internet for their members.

This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.

    Contacts:

    Barry A. Posner                             Rachel Levine
    Vice President                              Investor Relations
    MIM Corporation                             The Anne McBride Co.
    914-460-1638                                212-983-1702
    Email: investor_relations@mimhp.com         Email: rlevine@annemcbride.com

SOURCE MIM Corporation
CONTACT:
Web site: www.mimcorp.net